Anomalous behavior of CGP 12177A on β2-adrenergic receptors

Journal of Receptor and Signal Transduction Research

Volumn 16, Issue 42006, 1996, Pages 1-23

  Pak, Michael D ^a   Fishman, Peter H ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 (3 TERT BUTYLAMINO 2 HYDROXYPROPOXY) 2 BENZIMIDAZOLONE; BETA 1 ADRENERGIC RECEPTOR; CELL SURFACE RECEPTOR;

ANIMAL CELL; ARTICLE; BEHAVIOR; DRUG RECEPTOR BINDING; ENZYME ACTIVATION; GENE EXPRESSION; GLIOMA CELL; HYDROPHILICITY; INTERNALIZATION; MOLECULAR RECOGNITION; NONHUMAN; RAT; RECEPTOR AFFINITY; RECEPTOR DENSITY;

1-METHYL-3-ISOBUTYLXANTHINE; ADENYLATE CYCLASE; ADRENERGIC BETA-AGONISTS; ADRENERGIC BETA-ANTAGONISTS; ANIMALS; CELL LINE; CELL MEMBRANE; CRICETINAE; CYCLIC AMP; DOSE-RESPONSE RELATIONSHIP, DRUG; FORSKOLIN; GTP-BINDING PROTEINS; HUMANS; ISOPROTERENOL; PROPANOLAMINES; PROPRANOLOL; RATS; RECEPTORS, ADRENERGIC, BETA; STEREOISOMERISM; TRANSFECTION; ZINC;

EID: 0029945009     PISSN: 10799893     EISSN: None     Source Type: Journal    
DOI: 10.3109/10799899609039938     Document Type: Article

References (44)

1. Staehelin M., Simons P., Jaeggi K., Wigger N. CGP12177: a hydrophilic β-adrenergic receptor radioligand reveals high affinity binding of agonists to intact cells. J. Biol. Chem. 1983; 258: 3496 – 3502
2. Staehelin M., Simons P. Rapid and reversible disappearence of β-adrenergic cell surface receptors. EMBO J. 1982; 1: 187 – 190
3. Hertel C., Müller P., Portenier M., Staehelin M. Determination of the desensitization of β-adrenergic receptors by [3H]CCP-12177. Biochem. J. 1983; 216: 669 – 674
4. Kassis S., Olasmaa M., Sullivan M., Fishman P. H. Desensitization of the β-adrenergic receptor-coupled adenylate cyclase in cultured mammalian cells: receptor sequestration versus receptor function. J. Biol. Chem. 1986; 261: 12233 – 12237
5. Homburger V., Lucas M., Rosenbaum E., Vassent G., Bockaert J. Presence of bothbeta 1beta2adrenergic receptors in a single cell type. Mol. Pharmacol. 1981; 20: 463 – 469
6. Mohell N., Dicker A. The β-adrenergic radioligand [3H] CGP-12177, generally classified as an antagonist, is a thermogenic agonist in brown adipose tissue. Biochem. J. 1989; 261: 401 – 405
7. Scarpace P. J., Matheny M. Adenylate cyclase agonist properties of CGP-12177A in brown fat: evidence for atypical β-adrenergic receptors. Am. J. Physiol. 1991; 260: E226 – E231
8. Granneman J. G., Whitty C. J. CGP 12177A modulates brown fat adenylate cyclase activity by interacting with two distinct receptor sites. J. Pharmacol. Exp. Ther. 1991; 256: 421 – 425
9. Langin D., Portillo M. P., Saulnier-Blache J.-S., Lafontan M. Coexistence of three β-adrenoceptor subtypes in white fat cells of various mammalian species. Eur. J. Pharmacol. 1991; 199: 291 – 301
10. Feve B., Emorine L. J., Lasnier F., Blin N., Baude B., Nahmias C., Strosberg A. D., Pairault J. Atypical β-adrenergic receptor in 3T3-F442A adipocytes. Pharmacological and molecular relationship with the human β3-adrenergic receptor. J. Biol. Chem. 1991; 266: 20329 – 20336
11. Lönnqvist F., Krief S., Strosberg A. D., Nyberg B., Emorine L. J., Arner P. Evidence for a functional β3-adrenoceptor in man. Br. J. Pharmacol. 1993; 110: 929 – 936
12. Emorine L. J., Marullo S., Briend-Sutren M.-M., Patey G., Tate K., Delavier-Klutchko C., Strosberg A. D. Molecular characterization of the human β3-adrenergic receptor. Science (Washington D. C.) 1989; 245: 1118 – 1121
13. Granneman J. G., Lahners K. N., Chaudhry A. Molecular cloning and expression of the rat β3-adrenergic receptor. Mol. Pharmacol. 1991; 40: 895 – 899
14. Muzzin P., Revelli J.-P., Kuhne F., Gocayne J. F., McCombie W. R., Venter J. C., Giacobino J.-P., Fraser C. M. An adipose tissue-specific β-adrenergic receptor. Molecular cloning and down-regulation in obesity. J. Biol. Chem. 1991; 266: 24053 – 24058
15. Muzzin P., Revelli J.-P., Fraser C. M., Giacobino J.-P. Radioligand binding studies of the atypical β3-adrenergic receptor in rat brown adipose tissue using [3H]CGP 12177. FEBS Lett. 1992; 298: 162 – 164
16. Revelli J.-P., Muzzin P., Paoloni A., Moinat M., Giacobino J.-P. Expression of the β3-adrenergic receptor in human white adipose tissue. J. Mol. Endocrinol. 1993; 10: 193 – 197
17. Blin N., Camoin L., Maigret B., Strosberg A. D. Structural, and conformational features determining selective signal transduction in the β3-adrenergic receptor. Mol. Pharmacol. 1993; 44: 1094 – 1104
18. Sheppard J. R., Wehner J. M., McSwigan J. D., Shows T. B. Chromosomal assignment of the gene for the human β2-adrenergic receptor. Proc. Natl. Acad. Sci. USA 1983; 80: 233 – 236
19. Tate K. M., Briend-Sutren M.-M., Emorine L. J., Delavier-Klutchko C., Marullo S., Strosberg A. D. Expression of three human β-adrenergic-receptor subtypes in transfected Chinese hamster ovary cells. Eur. J. Biochem. 1991; 196: 357 – 361
20. Kobilka B. K., Dixon R. A. F., Frielle T., Dohlman H. G., Bolanowski M. A., Sigal I. S., Yang-Feng T. L., Francke U., Caron M. G., Lefkowitz R. J. cDNA for the human β2-adrenergic receptor: a protein with multiple membrane-spaning domains and encoded by a gene whose chromosomal location is shared with that of the receptor for platlet-derived growth factor. Proc. Natl. Acad. Sci. USA 1987; 84: 46 – 50
21. Frielle T. S., Collins S., Daniel K. W., Caron M. G., Lefkowitz R. J., Kobilka B. K. Cloning of the cDNA for the human β1-adrenergic receptor. Proc. Natl. Acad. Sci. U.S.A. 1987; 84: 7920 – 7924
22. Machida C. A., Bunzow J. R., Searles R. P., VanTol H., Tester B., Neve K. A., Teal P., Nipper V., Civelli O. Molecular cloning and expression of the rat β1-adrenergic receptor gene. J. Biol. Chem. 1991; 265: 12960 – 12965
23. Zhou X.-M., Pak M., Wang Z., Fishman P. H. Differences in desensitization between human β1- and β2-adrenergic receptors stably expressed in transfected hamster cells. Cellular. Signalling 1995; 7: 207 – 217
24. Zhou X.-M., Fishman P. H. Desensitization of the human β1-adrenergic receptor: involvement of the cyclic AMP-dependent but not a receptor-specific protein kinase. J. Biol. Chem. 1991; 266: 7462 – 7468
25. Fishman P. H., Nussbaum E., Duman R. S. Characterization and regulation of β1-adrenergic receptors in a human neuro-epithelioma cell line. J. Neurochem. 1991; 56: 596 – 602
26. Fishman P. H., Miller T., Curran P. K., Feussner G. K. Independent and coordinate regulation of β1- and β2-adrenergic receptors in rat C6 glioma cells. J. Receptor Res. 1994; 14: 281 – 296
27. Zaremba T. G., Fishman P. H. Desensitization of catechol-amine-stimulated adenylate cyclase and down-regulation of beta-adrenergic receptors in rat glioma C6 cells: role of cyclic AMP and protein synthesis. Mol. Pharmacol. 1984; 26: 206 – 213
28. Nanoff C., Freissmuth M., Schβtz W. The role of a low β1-adrenoceptor selectivity of [3H]CGP-12177 for resolving subtype-selectivity of competitive ligands. Naunyn Schmiedeberg's Arch. Pharmacol. 1987; 336: 519 – 525
29. Affolter H., Hertel C., Jaeggi K., Portenier M., Staehlin M. (-)-S-[3H]CGP-12177 and its use to determine the rate constants of unlabeled β-adrenergic antagonists. Proc. Natl. Acad. Sci. USA 1985; 83: 925 – 929
30. Hoyer D., Boddeke H. W.G. M. Partial agonist, full agonist, antagonists: dilemmas of definition. Trends Pharmacol. Sci. 1993; 14: 270 – 275
31. Zhu X., Gilbert S., Birnbaumer M., Birmbaumer L. Dual signaling potential is common among Gs-coupled receptors and dependent on receptor density. Mol. Pharmacol. 1994; 46: 460 – 469
32. Kenakin T. P. Agonist-receptor efficacy I: mechanisms of efficacy and receptor promiscuity. Trends Pharmacol. Sci. 1995; 16: 188 – 192
33. Kenakin T. P. Agonist-receptor efficacy I: agonist trafficking of receptor signals. Trends Pharmacol. Sci. 1995; 16: 232 – 238
34. Zhong H., Minneman K. P. Close reciprocal regulation of β1- and β2-adrenergic receptors by dexamethasone in C6glioma cells: effects on catecholamine responsiveness. Mol. Pharmacol. 1993; 44: 1085 – 1093
35. Jasper J. R., Michel M. C., Insel P. A. Amplification of cyclic AMP generation reveals agonistic effects of certain β-adrenergic antagonists. Mol. Pharmacol. 1990; 37: 44 – 49
36. Cervantes-Olivier P., Delavier-Klutchko C., Durieu-Trautmann O., Kaveri S., Desmandril M., Strosberg A. D. The β2-adrenergic receptors of human epidermoid carcinoma cells bear two different types of oligosaccharides which influence expression on the cell surface. Biochem. J. 1988; 250: 133 – 143
37. Boege F., Ward M., Jβrss R., Hekman M., Helmreich E. J. M. Role of glycosylation for β2-adrenoceptor function in A431 cells. J. Biol. Chem. 1988; 263: 9040 – 9049
38. O'Dowd B. F., Hnatowich M., Caron M. G., Lefkowitz R. J., Bouvier M. Palmitoylation of the human β2-adrenergic receptor. Mutation of Cys341in the carboxyl tail leads to an uncoupled nonpalmitoylated form of the receptor. J. Biol. Chem. 1989; 264: 7564 – 7569
39. Asano T., Katada T., Gilman A. G., Ross E. M. Activation of the inhibitory GTP-binding protein of adenylate cyclase, G1by β-adrenergic receptors in reconstituted phsopholipids vesicles. J. Biol. Chem. 1984; 259: 9351 – 9354
40. Mallorga P., Tallman J. F., Henneberry R. C., Hirata F., Strittmatter W. T., Axelrod J. Proc. Natl. Acad. Sci. USA 1980; 77: 1341 – 1345
41. DeLean A., Stadel J. M., Lefkowitz R. J. A ternary complex model explains the agonist-specific binding properties of the adenylate cyclase-coupled β-adrenergic receptor. J. Biol. Chem. 1980; 255: 7108 – 7117
42. Samama P., Cotecchia S., Costa T., Lefkowitz R. J. A mutation-induced activated state of the β2-adrenergic receptor. Extending the ternary complex model. J. Biol. Chem. 1993; 268: 4625 – 4636
43. Chidiac P., Hebert T. E., Valiquette M., Dennis M., Bouvier M. Inverse agonist activity of β-adrenergic antagonists. Mol. Pharmacol. 1994; 45: 490 – 499
44. Neubig R. R. Membrane organization in G-protein mechanisms. FASEB J. 1994; 8: 939 – 946